PetMed Express Files 8-K on Director Changes & Compensation
Ticker: PETS · Form: 8-K · Filed: Oct 21, 2025 · CIK: 1040130
| Field | Detail |
|---|---|
| Company | Petmed Express Inc (PETS) |
| Form Type | 8-K |
| Filed Date | Oct 21, 2025 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $1.3 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, executive-compensation, regulation-fd
Related Tickers: PETS
TL;DR
PETS 8-K: Director changes and compensation updates filed. Watch for details.
AI Summary
On October 19, 2025, PetMed Express, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also includes information regarding financial statements and exhibits, and a Regulation FD disclosure. Specific details on the individuals involved or the exact nature of the compensation changes were not provided in this excerpt.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and compensation can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Numbers
- 001-42429 — SEC File Number (Identifies the company's filing with the SEC.)
- 251407332 — Film Number (Internal SEC processing number for the filing.)
Key Players & Entities
- PETMED EXPRESS INC (company) — Registrant
- October 19, 2025 (date) — Date of earliest event reported
- Florida (location) — State of incorporation
- 650680967 (organization_id) — I.R.S. Employer Identification No.
- 420 South Congress Avenue, Delray Beach, Florida 33445 (address) — Principal executive offices
- ( 561 ) 526-4444 (phone_number) — Registrant's telephone number
FAQ
What specific changes were made to the board of directors?
The filing indicates a departure of directors or election of directors, but the specific names and details of these changes are not provided in the excerpt.
What are the details of the new compensatory arrangements?
The filing mentions compensatory arrangements of certain officers, but the specific details, amounts, or individuals involved are not included in this excerpt.
What is the primary reason for this 8-K filing?
The primary reasons for this 8-K filing are the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD Disclosure, and Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on October 19, 2025.
What is PetMed Express, Inc.'s principal executive office address?
PetMed Express, Inc.'s principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.
Filing Stats: 1,410 words · 6 min read · ~5 pages · Grade level 10.7 · Accepted 2025-10-21 16:22:21
Key Financial Figures
- $1.3 m — d will receive an annual base salary of $1.3 million, which may be increased in the di
Filing Documents
- pets-20251019.htm (8-K) — 37KB
- pets-xcampbellemploymentag.htm (EX-10.1) — 81KB
- pets-jameslacamppressrelea.htm (EX-99.1) — 15KB
- 0001040130-25-000077.txt ( ) — 314KB
- pets-20251019.xsd (EX-101.SCH) — 2KB
- pets-20251019_def.xml (EX-101.DEF) — 16KB
- pets-20251019_lab.xml (EX-101.LAB) — 27KB
- pets-20251019_pre.xml (EX-101.PRE) — 16KB
- pets-20251019_htm.xml (XML) — 4KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On October 20, 2025, the Company issued a press release announcing the appointment of Mr. LaCamp to the Board. A copy of such press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Description 10.1 Interim Executive Employment Agreement, dated October 20 2025, between the Company and Leslie C.G. Campbell 99.1 Press release dated October 20, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 3
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 21, 2025 PETMED EXPRESS, INC. By: /s/ Robert Lawsky Name: Robert Lawsky Title: General Counsel 4